Atlas Trials

Natural Killer-cell Therapy for Acute Myeloid Leukemia

Clinical trial NCT04347616 · TERMINATED

Trial details

NCT number
NCT04347616
Sponsor
Radboud University Medical Center
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, Relapsed, Adult
Start date
2020-12-03
Primary completion
2026-01-30
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.